Word

COMDOUMAB

Status

Dead

Status Code

602

Status Date

Wednesday, November 29, 2023

Serial Number

90894810

Mark Type

5000

Filing Date

Friday, August 20, 2021

Abandoned Date

Tuesday, August 15, 2023

Trademark Owner History

Akeso Pharmaceuticals, Inc.

Classifications

5 Pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; vaccines; biochemical medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; chemico-pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; biological preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for medical purposes; hemoglobin; medicines for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; Drugs, namely, pharmaceutical preparations for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia for human purposes; hematogen for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia; injectable medicinal solutions for the treatment of cancer, inflammation, blood diseases, asthma, skin disease and hypercholesterolemia

35 Retail store services and wholesale store services featuring medicines; Retail store services and wholesale stole services featuring pharmaceutical preparations; Retail store services and wholesale store services featuring sanitary preparations; Retail store services and wholesale store services featuring medical supplies; advertising and publicity services; publicity; organization of exhibitions and events for commercial or advertising purposes; marketing the goods and services of others by providing hyperlinks to websites of others; demonstration of goods; conducting market studies; business appraisals; business investigations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; import-export agency services

42 Technological research in the field of medicines and pharmaceutical preparations; research and development of new products for others; scientific laboratory services; product quality testing; conducting technical project studies in the nature of research in the field of pharmaceutical studies; chemical research; chemistry services, namely, research in the field of chemistry; chemical analysis; biological research; bacteriological research; medical and scientific research, namely, conducting clinical trials for others; scientific research

The mark consists of the stylized term "COMDOUMAB".

Trademark Events

Nov 29, 2023

Abandonment Notice E-Mailed - Failure To Respond

Nov 29, 2023

Abandonment Notice Mailed - Failure To Respond

Nov 29, 2023

Abandonment - Failure To Respond Or Late Response

May 10, 2023

Application Extension Granted/Receipt Provided

May 10, 2023

Application Extension To Response Period - Received

Feb 14, 2023

Notification Of Non-Final Action E-Mailed

Feb 14, 2023

Non-Final Action E-Mailed

Feb 14, 2023

Non-Final Action Written

Jan 27, 2023

Teas/Email Correspondence Entered

Jan 27, 2023

Correspondence Received In Law Office

Jan 27, 2023

Assigned To Lie

Nov 28, 2022

Teas Response To Office Action Received

Oct 4, 2022

Assigned To Examiner

May 26, 2022

Notification Of Non-Final Action E-Mailed

May 26, 2022

Non-Final Action E-Mailed

May 26, 2022

Non-Final Action Written

May 23, 2022

Assigned To Examiner

Oct 7, 2021

New Application Office Supplied Data Entered

Aug 24, 2021

New Application Entered